ADMA
Adma Biologics Inc
2 of the 83 super-investors we track hold ADMA, worth a combined $35M per their latest 13F filings. The largest position: Stanley Druckenmiller at 0.5% of their portfolio. This quarter the cohort logged 1 buy and 0 sells on the name. Conviction score: 45 of 100 (how strongly the cohort backs it) — ranked #73 of 742 stocks.
Why super-investors own ADMA
ADMA is held by 2 super-investors in our cohort, with a combined position value of $35M. The highest-conviction owner is Stanley Druckenmiller at 0.5% of their portfolio. Cohort ownership has grown from 1 to 2 over the last four quarters — net interest is rising. This quarter the cohort registered 1 added.
AI-synthesized from 13F filings. Not investment advice.
Cohort owners over time
2018Q1 → 2026Q2How many of the cohort members held this stock each quarter.
Owners (2) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Stanley Druckenmiller | 0.5% | 3q | $23M | 2,784,110 |
| 2 | Joel Greenblatt | <0.1% | 27q | $11M | 1,370,071 |
Owners of ADMA also hold
Recent activity (1)
| Manager | Move | % Port. | Δ Shares | Value | Filed |
|---|---|---|---|---|---|
| Stanley Druckenmiller | ADD | 0.5% | +80% | $23M | Aug 14, 2026 |
Long US equity 13F-HR filings only. CUSIP 000899104. Not investment advice.